Velimir Gayevskiy
Garvan Institute of Medical Research
45 Papers
71 Citations
Velimir Gayevskiy is an academic researcher from Garvan Institute of Medical Research. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 18, co-authored 39 publications. Previous affiliations of Velimir Gayevskiy include University of Auckland.
Chat about Author
Papers
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer.
Marie Wong,Marie Wong,Chelsea Mayoh,Loretta Lau,Loretta Lau,Dong Anh Khuong-Quang,Mark Pinese,Mark Pinese,Amit Kumar,Amit Kumar,Paulette Barahona,Emilie E. Wilkie,Patricia Sullivan,Rachel Bowen-James,Mustafa Syed,Inigo Martincorena,Federico Abascal,Alexandra Sherstyuk,Noemi A. Bolanos,Noemi A. Bolanos,Jonathan Baber,Peter Priestley,M. Emmy M. Dolman,Emmy D.G. Fleuren,Marie Gauthier,Emily Mould,Velimir Gayevskiy,Andrew J. Gifford,Dylan Grebert-Wade,Patrick Strong,Elodie Manouvrier,Meera Warby,David Thomas,Judy Kirk,Judy Kirk,Katherine M. Tucker,Tracey A. O'Brien,Tracey A. O'Brien,Frank Alvaro,Geoffry B. McCowage,Luciano Dalla-Pozza,Nicholas G. Gottardo,Nicholas G. Gottardo,Heather Tapp,Paul Wood,Seong Lin Khaw,Jordan R. Hansford,Andrew S. Moore,Andrew S. Moore,Murray D. Norris,Toby Trahair,Toby Trahair,Richard B. Lock,Vanessa Tyrrell,Michelle Haber,Glenn M. Marshall,Glenn M. Marshall,David S. Ziegler,David S. Ziegler,Paul G Ekert,Mark J. Cowley,Mark J. Cowley +61 more
TL;DR: Comprehensive molecular profiling resolved the molecular basis of virtually all high-risk cancers, leading to clinical benefit in some patients.
303
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
Jane Merlevede,Nathalie Droin,Tingting Qin,Kristen Meldi,Kenichi Yoshida,Margot Morabito,Emilie Chautard,Didier Auboeuf,Pierre Fenaux,Thorsten Braun,Raphael Itzykson,Stéphane de Botton,Bruno Quesnel,Thérèse Commes,Eric Jourdan,William Vainchenker,Olivier Bernard,Noémie Pata-Merci,Stéphanie Solier,Velimir Gayevskiy,Marcel E. Dinger,Mark J. Cowley,Dorothée Selimoglu-Buet,Vincent Meyer,François Artiguenave,Jean-François Deleuze,Claude Preudhomme,Michael R. Stratton,Ludmil B. Alexandrov,Ludmil B. Alexandrov,Eric Padron,Seishi Ogawa,Serge Koscielny,Maria E. Figueroa,Eric Solary +34 more
TL;DR: Serial sequencing demonstrates that the response to hypomethylating agents is associated with changes in DNA methylation and gene expression, without any decrease in the mutation allele burden, nor prevention of new genetic alteration occurence.
Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders
Lisa Ewans,Lisa Ewans,Deborah Schofield,Deborah Schofield,Deborah Schofield,Rupendra N. Shrestha,Ying Zhu,Velimir Gayevskiy,Kevin Ying,Corrina Walsh,Eric Lee,Edwin P. Kirk,Edwin P. Kirk,Edwin P. Kirk,Alison Colley,Carolyn Ellaway,Carolyn Ellaway,Anne M. Turner,Anne M. Turner,David Mowat,David Mowat,Lisa Worgan,Mary-Louise Freckmann,Mary-Louise Freckmann,Michelle Lipke,Rani Sachdev,Rani Sachdev,David Miller,Michael Field,Marcel E. Dinger,Marcel E. Dinger,Michael Buckley,Mark J. Cowley,Mark J. Cowley,Tony Roscioli,Tony Roscioli,Tony Roscioli +36 more
TL;DR: Early application of WES in Mendelian disorders is cost-effective and reanalysis of an undiagnosed individual at a 12-month time point increases total diagnoses by 11%.
178
Geographic delineations of yeast communities and populations associated with vines and wines in New Zealand.
TL;DR: It is shown that there are distinct regional delineations of yeast communities, but the picture for S. cerevisiae is more complex: there is evidence for region-specific sub-populations but there are also reasonable levels of gene flow among these regions in NZ.
MECR Mutations Cause Childhood-Onset Dystonia and Optic Atrophy, a Mitochondrial Fatty Acid Synthesis Disorder
Gali Heimer,Juha M. Kerätär,Lisa G. Riley,Shanti Balasubramaniam,Eran Eyal,Laura P. Pietikäinen,J. Kalervo Hiltunen,Dina Marek-Yagel,Jeffrey Hamada,Allison Gregory,Caleb Rogers,Penelope Hogarth,Martha Nance,Nechama Shalva,Alvit Veber,Michal Tzadok,Andreea Nissenkorn,Davide Tonduti,Florence Renaldo,Ichraf Kraoua,Celeste Panteghini,Lorella Valletta,Barbara Garavaglia,Mark J. Cowley,Velimir Gayevskiy,Tony Roscioli,Jonathon M. Silberstein,Chen Hoffmann,Annick Raas-Rothschild,Valeria Tiranti,Yair Anikster,John Christodoulou,Alexander J. Kastaniotis,Bruria Ben-Zeev,Susan J. Hayflick +34 more
TL;DR: The results suggest that mutations in MECR cause a distinct human disorder of the mtFAS pathway, and the observation of decreased lipoylation raises the possibility of a potential therapeutic strategy.
97